Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Industry By The Forecast Year 2029?

The chimeric antigen receptor-natural killer (CAR-NK) cell therapy market has experienced robust growth recently. Its size is projected to expand from $2.27 billion in 2024 to $2.42 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.6%. This historical growth can be attributed to several factors, including the global rise in cancer incidence, a growing focus on immunotherapy, early positive clinical results for natural killer (NK) cell therapies, government funding allocated to cancer research, and the expansion of cell therapy manufacturing facilities.

The chimeric antigen receptor-natural killer (CAR-NK) cell therapy market is anticipated to experience substantial expansion in the coming years, projected to reach $3.09 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.3%. This forecasted growth is attributable to factors such as increasing investments in cellular immunotherapy, a surge in partnerships between biotechnology and pharmaceutical firms, a rising need for readily available cancer treatments, the proliferation of clinical trials for chimeric antigen receptor-natural killer (CAR-NK) therapies, and the broader acceptance of precision oncology. Key trends during this period are expected to encompass technological breakthroughs in genetic engineering, novel approaches in chimeric antigen receptor (CAR) construct design, the establishment of allogeneic natural killer (NK) cell platforms, ongoing research and development focused on modulating the tumor microenvironment, and the incorporation of artificial intelligence (AI) into the development of cell therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27254&type=smp

Which Major Market Drivers Are Shaping The Future Of The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market?

The global rise in cancer cases is anticipated to propel the expansion of the chimeric antigen receptor-natural killer (CAR-NK) cell therapy market moving forward. Cancer refers to a collection of diseases characterized by the uncontrolled proliferation and spread of abnormal cells capable of invading and damaging body tissues. The increasing prevalence of cancer is attributable to factors such as aging populations and unhealthy lifestyles; older age leads to greater mutation accumulation over time, and poor habits like smoking, inadequate diet, and inactivity elevate cancer risk. Chimeric antigen receptor-natural killer (CAR-NK) cell therapy assists cancer treatment by genetically engineering natural killer cells to precisely identify and eradicate cancer cells, thereby enhancing the immune system’s targeted attack on tumors. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, estimated that the 20 million new cancer cases in 2022 are expected to increase by 77% to over 35 million cases in 2050. Therefore, the escalating incidence of cancer worldwide is driving the growth of the chimeric antigen receptor-natural killer (CAR-NK) cell therapy market.

What Are The Segment Types Shaping The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market?

The chimeric antigen receptor-natural killer (CAR-NK) cell therapy market covered in this report is segmented

1) By Type: Cytokine Therapy, Adoptive Natural Killer (NK) Cell Therapy, Genetically Engineered Natural Killer Cell Therapy, Other Types

2) By Cell Source: Peripheral Blood-Derived Natural Killer Cells, Cord Blood-Derived Natural Killer Cells, Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells, Natural Killer Cell Lines

3) By Application: Solid Tumors, Hematological Malignancies, Other Applications

4) By End User: Hospitals, Cancer Research Institutes, Biotechnology And Pharmaceutical Companies

Subsegments:

1) By Cytokine Therapy: Interleukin Therapy, Interferon Therapy, Colony Stimulating Factor Therapy, Tumor Necrosis Factor Therapy

2) By Adoptive Natural Killer Cell Therapy: Autologous Natural Killer Cell Therapy, Allogeneic Natural Killer Cell Therapy, Expanded Natural Killer Cell Therapy, Activated Natural Killer Cell Therapy

3) By Genetically Engineered Natural Killer Cell Therapy: Chimeric Antigen Receptor Natural Killer Cell Therapy, T Cell Receptor Engineered Natural Killer Cell Therapy, Gene Edited Natural Killer Cell Therapy, Cytokine Gene Modified Natural Killer Cell Therapy

4) By Other Types: Combination Therapy, Immune Checkpoint Inhibitor Therapy, Antibody Dependent Cellular Cytotoxicity Therapy, Oncolytic Virus Therapy

How Are Emerging Market Trends Shaping The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Industry Landscape?

Leading companies within the chimeric antigen receptor-natural killer (CAR-NK) cell therapy market are prioritizing the development of advanced solutions, such as conditioning chemotherapy-free treatment, to create safer and more effective off-the-shelf cellular therapies. This therapeutic method, conditioning chemotherapy-free treatment, eliminates the requirement for intense pre-treatment chemotherapy to suppress a patient’s immune system before cellular therapies are administered, thereby reducing toxicity and associated side effects. As an illustration, in November 2024, Fate Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, introduced FT522, an off-the-shelf CD19-targeted CAR NK cell therapy. This innovative treatment integrates alloimmune defense receptor technology, allowing CAR NK cells to persist and selectively deplete pathogenic B cells in patients with relapsed or refractory B-cell lymphoma and autoimmune diseases, demonstrating encouraging safety and efficacy results in early-phase clinical trials without the necessity for strong immune system suppression.

Who Are The Top Performing Companies In The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market In Recent Years?

Major companies operating in the chimeric antigen receptor-natural killer (CAR-NK) cell therapy market are Takeda Pharmaceutical Company Limited, Artiva Biotherapeutics Inc., Nkarta Inc., ImmunityBio Inc., Fate Therapeutics Inc., Acepodia Inc., PersonGen BioTherapeutics Inc., Cartherics Inc., Century Therapeutics Inc., Catamaran Bio Inc., Glycostem Therapeutics Ltd., ImmuneBridge Co. Ltd., ONK Therapeutics Inc., Senti Biosciences Inc., Wugen Therapeutics Inc., Chimeric Therapeutics Limited, East Ocyon Bio, Nuwacell Biotechnologies Co. Ltd., Nkarta Therapeutics Inc., and GICELL Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chimeric-antigen-receptor-natural-killer-car-nk-cell-therapy-global-market-report

What Are The Key Regional Factors Influencing The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Growth?

North America was the largest region in the chimeric antigen receptor-natural killer (CAR-NK) cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chimeric antigen receptor-natural killer (CAR-NK) cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27254&type=smp

Browse Through More Reports Similar to the Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market 2025, By The Business Research Company

Home Healthcare Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/home-healthcare-equipment-global-market-report

Computer Peripheral Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computer-peripheral-equipment-global-market-report

Mortuary Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mortuary-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model